Search Results - "Malankar, Pradeep "

Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial by Sutter, Roland W, Dr, John, T Jacob, Prof, Jain, Hemant, Prof, Agarkhedkar, Sharad, Prof, Ramanan, Padmasani Venkat, Prof, Verma, Harish, MB, Deshpande, Jagadish, PhD, Singh, Ajit Pal, MB, Sreevatsava, Meghana, MPH, Malankar, Pradeep, MD, Burton, Anthony, Chatterjee, Arani, MB, Jafari, Hamid, MD, Aylward, R Bruce, MD

“…Summary Background Poliovirus types 1 and 3 co-circulate in poliomyelitis-endemic countries. We aimed to assess the immunogenicity of a novel bivalent types 1…”
Get full text

Fractional Doses of Inactivated Poliovirus Vaccine in Oman by Mohammed, Ali Jafer, AlAwaidy, Salah, Bawikar, Shyam, Kurup, Padmamohan J, Elamir, Emadaldin, Shaban, Mahmoud M.A, Sharif, Sharif M, van der Avoort, Harrie G.A.M, Pallansch, Mark A, Malankar, Pradeep, Burton, Anthony, Sreevatsava, Meghana, Sutter, Roland W

“…Determining an economically sustainable way to deliver the poliovirus vaccine remains a challenge and a priority. In this article, investigators in Oman show…”
Get full text

Sequential Use of Inactivated Poliovirus Vaccine followed by Oral Poliovirus Vaccine in Oman by Sutter, Roland W., Suleiman, Ali Jaffer M., Malankar, Pradeep G., Mehta, Firdosi R., Medany, Mahmud A., Arif, Mohammed Amir M., Linkins, Robert W., Pallansch, Mark A., El-Bualy, Mussalam S., Robertson, Susan E.

“…Seroprevalence and geometric mean titers (GMTs) were compared at 6 and 10 months after vaccination with monovalent type 1 oral poliovirus vaccine (OPV) at 6…”
Get full text

Monovalent Type 1 Oral Poliovirus Vaccine in Newborns by El-Sayed, Nasr, El-Gamal, Yehia, Abbassy, Ahmed-Amr, Seoud, Iman, Salama, Maha, Kandeel, Amr, Hossny, Elham, Shawky, Ahmed, Hussein, Heba Abou, Pallansch, Mark A, van der Avoort, Harrie G.A.M, Burton, Anthony H, Sreevatsava, Meghana, Malankar, Pradeep, Wahdan, Mohamed H, Sutter, Roland W

“…One potential tool in the quest for global eradication of poliomyelitis is a newly developed monovalent type 1 oral poliovirus vaccine. In this study involving…”
Get full text

Monovalent type 1 oral poliovirus vaccine among infants in India: Report of two randomized double-blind controlled clinical trials by John, T. Jacob, Jain, Hemant, Ravishankar, Kanithi, Amaresh, A, Verma, Harish, Deshpande, Jagadish, Pallansch, Mark A, Singh, Ajit Pal, Sreevatsava, Meghana, Burton, Anthony, Malankar, Pradeep, Chatterjee, Arani, Sutter, Roland W

“…Highlights ► Study demonstrated the superiority of monovalent type 1 oral poliovirus vaccine (mOPV1) over trivalent oral poliovirus vaccine (tOPV) when given…”
Get full text

Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine by Sutter, R W, Patriarca, P A, Suleiman, A J, Pallansch, M A, Zell, E R, Malankar, P G, Brogan, S, al-Ghassani, A A, el-Bualy, M S

“…Variation in attack rates of paralytic disease by region during the 1988-1989 epidemic of type 1 poliomyelitis in Oman provided the stimulus to test the…”
Get more information

Trial of a Supplemental Dose of Four Poliovirus Vaccines by Sutter, Roland W, Suleiman, Ali Jaffer M, Malankar, Pradeep, Al-Khusaiby, Saleh, Mehta, Firdosi, Clements, Geoff B, Pallansch, Mark A, Robertson, Susan E

“…The immunogenicity of oral poliovirus vaccine (OPV) is lower in infants in many developing countries than in infants in industrialized countries. 1 – 5 A…”
Get full text

Immunogenicity of measles and rubella vaccines in Oman: A prospective clinical trial: Global measles mortality reduction and regional elimination: a status report by KOHLER, Kathryn A, SULEIMAN, Ali Jaffer M, ROBERTSON, Susan E, MALANKAR, Pradeep, AL-KHUSAIBY, Saleh, HELFAND, Rita F, BROWN, David, BELLINI, William J, SUTTER, Roland W

Get full text

Immunogenicity of Measles and Rubella Vaccines in Oman: A Prospective Clinical Trial by Kohler, Kathryn A. , Suleiman, Ali Jaffer M. , Robertson, Susan E. , Malankar, Pradeep , Al‐Khusaiby, Saleh , Helfand, Rita F. , Brown, David , Bellini, William J. , Sutter, Roland W. 

“…A prospective immunogenicity trial of measles and rubella vaccines was conducted in Oman. Children received measles vaccine at age 9 months and measles‐rubella…”
Get full text

Attributable Risk of DTP (Diphtheria and Tetanus Toxoids and Pertussis Vaccine) Injection in Provoking Paralytic Poliomyelitis during a Large Outbreak in Oman by Sutter, Roland W., Patriarca, Peter A., Suleiman, Ali Jaffer M., Brogan, Shaun, Malankar, Pradeep G., Cochi, Stephen L., Al-Ghassani, Ahmed A. K., El-Bualy, Musallam S.

“…Although injections administered during the incubation period of wild poliovirus infection have been associated with an increased risk of paralytic…”
Get full text